Contacter le RP

Pour utiliser cette fonctionnalité, vous devez bénéficier d'un compte Babbler.

arrow_back

Babbler permet aux journalistes et communicants de collaborer plus simplement.

En vous connectant, vous pourrez accéder gratuitement aux espaces presse des centaines d'entreprises de vos secteurs qui sont sur Babbler, entrer en contact direct avec leurs équipes RP mais aussi y partager vos prochains sujets !

Leurs espaces presse sont sur Babbler :

Vous êtes à 1 clic de l'inscription !

Précédent

Content de vous revoir !

Communiqué

間葉系幹細胞(MSC)の世界市場規模、成長機会、主要国データ、将来の動向、収益予測とのシェア(2022~2031年)
timer minutes de lecture minute de lecture

Copier le lien
世界の間葉系幹細胞(MSC)市場は、慢性疾患の症例の増加により、2022年から2031年の間に約14%のCAGRで成長する

Cliquez sur l'image pour obtenir le format original

Kenneth Research has published a report titled “Mesenchymal Stem Cell (MSC) Market: Global Demand Analysis and Opportunity Outlook 2031” which provides a detailed overview of the global mesenchymal stem cell (MSC) market in terms of market segmentation by type. treatment, product and service, isolation source, application, stem cell indication and by region.

Access the full report description: https://www.kennethresearch.com/report-details/mesenchymal-stem-cells-market/10082369

Additionally, for the in-depth analysis, the report encompasses industry growth indicators, restraints, supply and demand risk along with a detailed discussion of current and future market trends associated with the market growth.

The global mesenchymal stem cell (MSC) market generated revenue of around USD 3 billion in 2021 and is expected to grow at a CAGR of around 14% during the forecast period, i.e. say from 2022 to 2031. Based on application, the market is segmented into disease modeling, oncology disorders, drug development and discovery, stem cell banking, tissue engineering, and others. Among these sub-segments, the oncology disorders segment is expected to grow with the highest CAGR during the forecast period owing to the increase in lifespan, which in turn leads to higher risk or cases of cancer.

As the incidence of chronic diseases is increasing, MSC is considered the most effective treatment, which is expected to drive the demand for mesenchymal stem cell treatment. Additionally, MSCs are multipotent stromal cells that can be differentiated into a variety of cell types that generate a effective approach to treatment. These factors are expected to drive the growth of the global mesenchymal stem cell market over the forecast period.

Regionally, the global mesenchymal stem cell market is segmented into five major regions including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The market in the Asia-Pacific region is expected to grow at a high CAGR during the forecast period. The market in China and India is estimated to be the major countries in the region where the demand for MSC is expected to witness significant growth. The growing number of aging patients and the government initiative of the government initiative such as check camps, sufficient healthcare sector funding and many more to help in the growth of the market and create awareness about the availability of different types of MSC treatments 

are the major market growth factors in this region.

The research is global in nature and covers detailed analysis of the market in North America (US, Canada), Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands and Luxembourg, NORDIC Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, Oman] , North Africa, South Africa, rest of the Middle East and Africa). Further, analysis including market size, YOY growth and opportunity analysis, competitive study of market players, prospects, etc. were also covered and displayed in the research report.


Active investments from leading companies in stem cell biology to fuel market growth

The mesenchymal stem cell market is expected to grow rapidly in the coming years. Investors in this field are looking for the research and development opportunity and are investing heavily in MSC therapy which is one of the major factors expected to drive the growth of the market. In addition to private companies, government subsidiaries are actively investing in research and development of new products and educating people about the effectiveness of MSC treatment. 

However, the lack of stem cell-related therapeutic advancement is expected to be a key restraint for the growth of the global mesenchymal stem cell market in the forecast period.

This report also provides the existing competitive scenario of some of the major players in the global Mesenchymal Stem Cells Market which includes company profiling of Cell Applications, Inc., Celprogen Inc., STEMCELL Technologies Inc., Axol Bioscience Ltd., Cytori Therapeutics Inc., Proteona Pte. Ltd., BrainStorm Cell Limited, Stemedica Cell Technologies, Inc., Mesoblast Ltd., ScienCell Research Laboratories, Inc., Neuromics and others. Profiling includes key business information that encompasses an overview of business, products and services, key financials, and recent news and developments. Overall, the report depicts an in-depth overview of the global Mesenchymal Stem Cells Market which will help industry consultants, expansion opportunities, new players looking for opportunities, and other stakeholders to align their market-centric strategies with current and expected future trends.      

Get a strategic sample of the report: https://www.kennethresearch.com/sample-request-10082369

Kenneth Research is a leading provider of strategic market research and consulting services. We aim to provide unbiased and unmatched market insights and industry analysis to help industries, conglomerates and executives make sound decisions for their future marketing strategy, expansion and investments etc. We believe that every business can expand to its new horizon, provided the right direction at the right time is available through strategic minds. Our original thinking helps our clients make sound decisions to avoid future uncertainties.

Contact for more information:

AJ Daniel

Email: sales@kennethresearch.com

Telephone in the United States: +1 313 462 0609 


Autres actualités de la marque

inscrit avec succès

Félicitations, vous êtes inscrit sur BABBLER !

Pour découvrir dès maintenant toutes les actualités qui vous attendent sur Babbler, consultez votre newsfeed !

Vos domaines ont été préselectionnés. Vous pouvez les compléter en cliquant ici